Targeting GPCR with skin-permeable peptides

50

peptides active
in vitro

INCI

requirements
satisfied

Non-toxic

skin-permeable peptides
in vitro

90 nM

IC50 of the best
peptide

*Known ligand: small molecule antagonist
(blurred)

01/ Background

  • ‍‍The target is a GPCR driving protease-induced itch and inflammation.
  • The goal is to design skin-permeable linear peptide antagonist
(4-10 AAs).
  • Peptides must be INCI-compliant.
  • No protein binders known.

02/ Methodology

  • MD performed on target protein, 5 conformations were selected.
  • 10 starting peptides were AI-generated inside the binding pocket.
  • In-pocket peptide optimization under mutation rules aligned with INCI-requirements.
  • 34 ADME-Tox and 36 PhysChem parameters computed.
  • ~2K peptides were shortlisted for visual analysis.
  • ~100 peptides were selected for validation.

03/ Results

  • 50 peptides are active in vitro
  • Skin permeability achieved for all hits.
  • No toxic effect observed in vitro.
  • The top hit shows IC50 90 nM.

04/ Binding pose

  • The 6-mer peptide spans hydrophobic grooves and polar hotspots.
  • 7 residues involved in conventional H-bonds.
  • Additional π-π/σ and π-alkyl interactions complete the fit.
*Binding pose of one of the top peptides